Tag results:
Publication
Newsletters
Delivery of a BET Protein Degrader via a CEACAM6-Targeted Antibody–Drug Conjugate Inhibits Tumor Growth in Pancreatic Cancer Models
[Nature Communications] To improve PDAC therapy, researchers established screening systems based on organoid and co-culture technologies and found a payload of antibody–drug conjugate, a bromodomain and extra-terminal (BET) protein degrader named EBET.
Newsletters
PRMT1 Promotes Pancreatic Cancer Development and Resistance to Chemotherapy
[Cell Reports Medicine] Investigators showed that PRMT1 was highly expressed in murine and human pancreatic cancer and was essential for cancer cell proliferation and tumorigenesis.
ESC & iPSC News
H2AK119ub1 Differentially Fine-Tunes Gene Expression by Modulating Canonical PRC1- and H1-Dependent Chromatin Compaction
[Molecular Cell] Researchers revealed that H2AK119ub1 had two distinct roles in gene expression, through differentially modulating chromatin compaction mediated by canonical polycomb repressive complex 1 (PRC1) and the linker histone H1.
ESC & iPSC News
ATG5 Nonautophagically Regulates Inflammation and Differentiation in Mouse Embryonic Stem Cells
[Autophagy] Investigators demonstrated that macroautophagy/autophagy-related protein ATG5 inhibited the inflammatory response of mouse ESCs by promoting the degradation of BTRC/β-TrCP1 and further the downregulation of NFKB/NF-κB signaling.
ESC & iPSC News
Di-n-Butyl Phthalate Promotes the Neural Differentiation of Mouse Embryonic Stem Cells through Neurogenic Differentiation 1
[Environmental Pollution] Researchers focused on the characterization of the genetic traits and alterations in pluripotency/stemness triggered by phthalate ester derivatives. They reported the abilities of ESCs regarding proliferation, cell-cycle control, and neural ectoderm differentiation.
ESC & iPSC News
Improving Cardiac Differentiation of Human Pluripotent Stem Cells by Targeting Ferroptosis
[Regenerative Therapy] Scientists increased the efficiency of generating cardiomyocytes from hPSCs. They identified cell death as a detrimental factor during this initial stage of in vitro cardiomyocyte differentiation.